IR
Healthcare & Life Sciences
iRegene
Chinairegene.com
iRegene is a Healthcare & Life Sciences startup based in China, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About iRegene
iRegene is a startup based in China. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
iRegene develops first-in-class induced pluripotent stem cell (iPSC) therapies to cure incurable diseases such as Parkinson's Disease, Multiple System Atrophy, and retinal degenerative diseases using advanced gene editing and AI-powered omics discovery platforms.
Explore iRegene's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.